Financials

  • Market Capitalization 9.16 B
  • Employee 5 654
  • Founded 1984
  • CEO Thierry Bernard
  • Website www.qiagen.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
23.18
市销率
4.79
每股股息
0.25
股息收益率 %
0.56

Qiagen N.V

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.

新闻